A Pediatric Taste Test Study of Omnicef Versus Zithromax Antibiotic Suspension Medications

This study has been completed.
Sponsor:
Information provided by:
Abbott
ClinicalTrials.gov Identifier:
NCT00644774
First received: March 22, 2008
Last updated: March 26, 2008
Last verified: March 2008
  Purpose

To compare the taste and smell acceptability of cefdinir (Omnicef) antibiotic suspension and azithromycin (Zithromax) antibiotic suspension following a single dose of each medication.


Condition Intervention Phase
Healthy
Drug: cefdinir (Omnicef)
Drug: azithromycin
Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Single Blind (Subject)
Official Title: A Comparative, Multi-Center, Pediatric Taste Test Study of Omnicef Versus Zithromax Antibiotic Suspension Medications

Resource links provided by NLM:


Further study details as provided by Abbott:

Primary Outcome Measures:
  • Taste and smell acceptance and preference [ Time Frame: 2 hours ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Adverse events assessment [ Time Frame: 72 hours with follow-up to a satisfactory conclusion ] [ Designated as safety issue: Yes ]
  • Concomitant Medications [ Time Frame: 72 hours ] [ Designated as safety issue: Yes ]
  • Vital signs [ Time Frame: 2 hours ] [ Designated as safety issue: Yes ]
  • Any clinically abnormal observations [ Time Frame: 2 hours with follow-up to a satisfactory conclusion ] [ Designated as safety issue: Yes ]

Enrollment: 157
Study Start Date: January 2003
Primary Completion Date: January 2003 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: 1 Drug: cefdinir (Omnicef)
2.5 ml of strawberry cream flavored oral suspension 125 mg/5 ml
Other Names:
  • ABT-198
  • Omnicef
  • cefdinir
Active Comparator: 2 Drug: azithromycin
2.5 ml of cherry flavored oral suspension 100 mg/5 ml
Other Name: Zithromax

Detailed Description:

The Primary Purpose for the study is "Other". Per ClinicalTrias.gov, more information regarding the primary purpose is described here; this study is a pediatric taste test.

  Eligibility

Ages Eligible for Study:   4 Years to 8 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Female or male child age 4 through 8 years in good general health.
  • Minimum weight of 16.3 kg (36 lb).
  • Willing to comply with appropriate instructions provided to complete the study.
  • Written informed consent from parent/legal guardian.

Exclusion Criteria:

  • Current medical condition, that in the opinion of the Investigator or designee, may interfere with the ability to discriminate taste (e.g., common cold, sinus infection, bronchial infection, etc.).
  • History of allergic reaction to cefdinir, azithromycin, prescription (e.g. penicillins or cephalosporins) and/or OTC medications, and/or food products.
  • History of significant medical condition (e.g., GI disorders, hematological or bleeding disorders, renal or hepatic diseases).
  • Use of any oral medication, vitamins or herbal supplements within 6 hours prior to tasting.
  • Temperature > than 99.2°F. Participation in a clinical or marketing research study within the past 3 months.
  • Sibling of another subject on the study, or living in the same household as another subject that has participated in a clinical or marketing research study within the past 3 months.
  • Family member or close friend employed by an advertising agency, market research company, and/or a company that processes or manufacturers medical or health care products.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00644774

Locations
United States, Arizona
Scottsdale, Arizona, United States, 85251
United States, Florida
St. Petersburg, Florida, United States, 33710
United States, Ohio
Miamiville, Ohio, United States, 45147
Sponsors and Collaborators
Abbott
  More Information

No publications provided

Responsible Party: Angela M Nilius, Abbott
ClinicalTrials.gov Identifier: NCT00644774     History of Changes
Other Study ID Numbers: M02-568
Study First Received: March 22, 2008
Last Updated: March 26, 2008
Health Authority: United States: Food and Drug Administration

Keywords provided by Abbott:
pediatric taste test
antibiotic taste test
cefdinir
azithromycin

Additional relevant MeSH terms:
Anti-Bacterial Agents
Antibiotics, Antitubercular
Cefdinir
Anti-Infective Agents
Antitubercular Agents
Pharmacologic Actions
Therapeutic Uses

ClinicalTrials.gov processed this record on October 21, 2014